These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22022529)

  • 21. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motor cortical excitability and paired-associative stimulation-induced plasticity in amnestic mild cognitive impairment and Alzheimer's disease.
    Meder A; Liepelt-Scarfone I; Sulzer P; Berg D; Laske C; Preische O; Desideri D; Zipser CM; Salvadore G; Tatikola K; Timmers M; Ziemann U
    Clin Neurophysiol; 2021 Sep; 132(9):2264-2273. PubMed ID: 33612394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulcal morphology changes and their relationship with cortical thickness and gyral white matter volume in mild cognitive impairment and Alzheimer's disease.
    Im K; Lee JM; Seo SW; Hyung Kim S; Kim SI; Na DL
    Neuroimage; 2008 Oct; 43(1):103-13. PubMed ID: 18691657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered parietal-motor connections in Alzheimer's disease patients.
    Bonnì S; Lupo F; Lo Gerfo E; Martorana A; Perri R; Caltagirone C; Koch G
    J Alzheimers Dis; 2013; 33(2):525-33. PubMed ID: 23001709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic treatment with rivastigmine in patients with Alzheimer's disease: a study on primary motor cortex excitability tested by 5 Hz-repetitive transcranial magnetic stimulation.
    Trebbastoni A; Gilio F; D'Antonio F; Cambieri C; Ceccanti M; de Lena C; Inghilleri M
    Clin Neurophysiol; 2012 May; 123(5):902-9. PubMed ID: 21996001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical excitability in very mild Alzheimer's disease: a long-term follow-up study.
    Olazarán J; Prieto J; Cruz I; Esteban A
    J Neurol; 2010 Dec; 257(12):2078-85. PubMed ID: 20680325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher motor cortical excitability linked to greater cognitive dysfunction in Alzheimer's disease: results from two independent cohorts.
    Zadey S; Buss SS; McDonald K; Press DZ; Pascual-Leone A; Fried PJ
    Neurobiol Aging; 2021 Dec; 108():24-33. PubMed ID: 34479168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity.
    Alagona G; Bella R; Ferri R; Carnemolla A; Pappalardo A; Costanzo E; Pennisi G
    Neurosci Lett; 2001 Nov; 314(1-2):57-60. PubMed ID: 11698146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electroencephalographic upper/low alpha frequency power ratio relates to cortex thinning in mild cognitive impairment.
    Moretti DV; Paternicò D; Binetti G; Zanetti O; Frisoni GB
    Neurodegener Dis; 2014; 14(1):18-30. PubMed ID: 24434624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurophysiological features of motor cortex excitability and plasticity in Subcortical Ischemic Vascular Dementia: a TMS mapping study.
    Guerra A; Petrichella S; Vollero L; Ponzo D; Pasqualetti P; Määttä S; Mervaala E; Könönen M; Bressi F; Iannello G; Rossini PM; Ferreri F
    Clin Neurophysiol; 2015 May; 126(5):906-13. PubMed ID: 25262646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
    Jack CR; Lowe VJ; Senjem ML; Weigand SD; Kemp BJ; Shiung MM; Knopman DS; Boeve BF; Klunk WE; Mathis CA; Petersen RC
    Brain; 2008 Mar; 131(Pt 3):665-80. PubMed ID: 18263627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The correspondence between EMG and EEG measures of changes in cortical excitability following transcranial magnetic stimulation.
    Biabani M; Fornito A; Coxon JP; Fulcher BD; Rogasch NC
    J Physiol; 2021 Jun; 599(11):2907-2932. PubMed ID: 33599980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment.
    Bokde AL; Lopez-Bayo P; Meindl T; Pechler S; Born C; Faltraco F; Teipel SJ; Möller HJ; Hampel H
    Brain; 2006 May; 129(Pt 5):1113-24. PubMed ID: 16520329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.
    Liu Y; Paajanen T; Zhang Y; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    Neurobiol Aging; 2010 Aug; 31(8):1375-85. PubMed ID: 20447732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer's disease differ according to disease severity and amyloid positivity.
    Park JE; Yun J; Kim SJ; Shim WH; Oh JS; Oh M; Roh JH; Seo SW; Oh SJ; Kim JS
    PLoS One; 2019; 14(12):e0226265. PubMed ID: 31834916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia.
    Cantone M; Di Pino G; Capone F; Piombo M; Chiarello D; Cheeran B; Pennisi G; Di Lazzaro V
    Clin Neurophysiol; 2014 Aug; 125(8):1509-32. PubMed ID: 24840904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortical thickness in relation to clinical symptom onset in preclinical AD.
    Pettigrew C; Soldan A; Zhu Y; Wang MC; Moghekar A; Brown T; Miller M; Albert M;
    Neuroimage Clin; 2016; 12():116-22. PubMed ID: 27408796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease.
    Singh V; Chertkow H; Lerch JP; Evans AC; Dorr AE; Kabani NJ
    Brain; 2006 Nov; 129(Pt 11):2885-93. PubMed ID: 17008332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation study.
    Ferreri F; Pauri F; Pasqualetti P; Fini R; Dal Forno G; Rossini PM
    Ann Neurol; 2003 Jan; 53(1):102-8. PubMed ID: 12509853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.